Insider Transactions in Q3 2023 at Verona Pharma PLC (VRNA)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 07
2023
|
Claire Poll General Counsel |
BUY
Bona fide gift
|
Indirect |
89,976
+9.43%
|
-
|
|
Aug 07
2023
|
Claire Poll General Counsel |
SELL
Bona fide gift
|
Direct |
89,976
-4.72%
|
-
|
|
Aug 07
2023
|
Claire Poll General Counsel |
SELL
Open market or private sale
|
Direct |
1,512
-0.08%
|
$3,024
$2.47 P/Share
|
|
Aug 07
2023
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,616
-0.06%
|
$17,232
$2.47 P/Share
|
|
Aug 07
2023
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
8,616
-0.05%
|
$17,232
$2.47 P/Share
|
|
Aug 07
2023
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,600
-0.06%
|
$3,200
$2.47 P/Share
|
|
Aug 04
2023
|
Claire Poll General Counsel |
SELL
Open market or private sale
|
Direct |
26,352
-1.36%
|
$52,704
$2.5 P/Share
|
|
Aug 04
2023
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
150,000
-0.96%
|
$300,000
$2.5 P/Share
|
|
Aug 04
2023
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
150,000
-0.9%
|
$300,000
$2.5 P/Share
|
|
Aug 04
2023
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
27,944
-0.96%
|
$55,888
$2.5 P/Share
|
|
Aug 03
2023
|
Claire Poll General Counsel |
SELL
Open market or private sale
|
Direct |
20,608
-1.05%
|
$41,216
$2.54 P/Share
|
|
Aug 03
2023
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
117,272
-0.74%
|
$234,544
$2.54 P/Share
|
|
Aug 03
2023
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
117,272
-0.7%
|
$234,544
$2.54 P/Share
|
|
Aug 03
2023
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
50,600
-0.86%
|
$101,200
$2.55 P/Share
|
|
Aug 02
2023
|
Claire Poll General Counsel |
SELL
Open market or private sale
|
Direct |
12,944
-0.66%
|
$25,888
$2.59 P/Share
|
|
Aug 02
2023
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
73,704
-0.46%
|
$147,408
$2.59 P/Share
|
|
Aug 02
2023
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
13,728
-0.46%
|
$27,456
$2.59 P/Share
|
|
Aug 02
2023
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
73,704
-0.44%
|
$147,408
$2.59 P/Share
|
|
Aug 01
2023
|
Claire Poll General Counsel |
SELL
Open market or private sale
|
Direct |
18,608
-0.94%
|
$37,216
$2.68 P/Share
|
|
Aug 01
2023
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
105,944
-0.66%
|
$211,888
$2.68 P/Share
|
|
Aug 01
2023
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
19,736
-0.66%
|
$39,472
$2.68 P/Share
|
|
Aug 01
2023
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
105,944
-0.63%
|
$211,888
$2.68 P/Share
|